SCHEMBL16975153

SCHEMBL16975153

CCOC(=O)[C@@H](CC(N)Cc1ccc(-c2cc(Cl)ccc2F)cc1)N=[N+]=[N-]

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.51
▸ ACE P12821 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16975182 1.00 MME (0.51) MMEACE
SCHEMBL16930471 1.00 MME (0.51) MMEACE
SCHEMBL18868466 0.88 MME (0.45) MMEACE
SCHEMBL16930630 0.88 MME (0.45) MMEACE
SCHEMBL16975166 0.88 MME (0.45) MMEACE
SCHEMBL16939255 0.86 MME (0.49) MMEACE
SCHEMBL20306299 0.85 MME (0.53) MMEACE
SCHEMBL16939260 0.85 MME (0.63) MMEACE
SCHEMBL16979113 0.85 MME (0.63) MMEACE
SCHEMBL17980192 0.84 MME (0.55) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3099678-A1 NEPRILYSIN INHIBITORS Theravance Biopharma R&D IP, LLC (US) 2016-12-07 — — EP disclosed
WO-2015116786-A1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2015-08-06 — — WO disclosed
Send feedback